Genetic susceptibility to macrovascular complications of type 2 diabetes mellitus.
Patients with type 2 diabetes mellitus have a threefold increased risk of developing macrovascular disease such that 75% of such patients will die of cardiovascular complications. This increased risk is, however, not completely explained by traditional risk factors such as smoking, hypercholesterolaemia, hypertension and glycaemic control. Moreover, the fact that not all patients with type 2 diabetes develop these complications, together with evidence of family clustering (a heritability of 50%), suggests that a proportion of the susceptibility to ischaemic heart disease in type 2 diabetes may be genetic. Unravelling the polygenic susceptibility factors for the complications of a disease that itself has multifactorial inheritance has proved difficult and has focused largely on the candidate gene approach. A review of some of the studies testing candidate genes specifically in patients with both type 2 diabetes and ischaemic heart disease is presented. These studies focus largely on four main areas: lipoprotein metabolism, glycation and oxidation pathways, haemostatic cascade, and other candidate genes.
Barakat
K
K
Department of Diabetes and Metabolic Medicine and Cardiology, Barts, UK.
Hitman
G A
GA
D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000235:genetics*; D003925:Diabetic Angiopathies / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006031:Glycosylation; D006487:Hemostasis / Q000235:genetics; D006801:Humans; D008074:Lipoproteins / Q000235:genetics; D017202:Myocardial Ischemia / Q000235:genetics; D010084:Oxidation-Reduction
D008074:Lipoproteins